ENDV
NDONOVO THERAPEUTICS INCstockOTC
endonovo therapeutics (otcqb: endv) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. endonovo's immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. endonovo's cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and time-varying electromagnetic fields (tvemf) for tissue engineering and cell therapies.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.00 | 2026-11-10 | +9900.00% | -13961.235 |
| 6M | 0.00 | 2026-05-26 | +9900.00% | -44.832 |
| 2Y | 0.00 | 2024-11-19 | -88.89% | — |
| 5Y | 0.02 | 2021-11-19 | -99.42% | -7.271 |
NDONOVO THERAPEUTICS INC (OTC:ENDV) stock price today is $0.00, and today's volume is 200,000. ENDV is up 0.000% today. The 30 day average volume is 562,216. ENDV market cap is $39,683 with 396.83M shares outstanding.